Meiko Trans Co (9357) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
13 Mar, 2026Executive summary
Net sales for the six months ended September 30, 2024, rose 3.3% year-over-year to ¥40,235 million.
Operating profit increased 7.8% year-over-year to ¥2,974 million.
Ordinary profit grew 12.0% year-over-year to ¥3,858 million.
Profit attributable to owners of parent was ¥2,483 million, up 2.9% year-over-year.
Comprehensive income surged to ¥8,206 million from ¥2,886 million a year earlier.
Financial highlights
Gross profit increased to ¥8,529 million from ¥7,934 million year-over-year.
Basic earnings per share for the period was ¥83.13, up from ¥80.86 year-over-year.
Total assets as of September 30, 2024, were ¥152,147 million, up from ¥151,026 million as of March 31, 2024.
Net assets increased to ¥124,140 million from ¥121,792 million at the previous fiscal year-end.
Capital adequacy ratio improved to 78.2% from 77.3% as of March 31, 2024.
Outlook and guidance
Full-year net sales forecasted at ¥80,000 million, up 3.0% year-over-year.
Operating profit projected at ¥5,800 million, up 10.1% year-over-year.
Ordinary profit expected to reach ¥7,400 million, up 13.2% year-over-year.
Profit attributable to owners of parent forecasted at ¥5,000 million, up 10.1% year-over-year.
Basic earnings per share for the full year projected at ¥167.36.
Latest events from Meiko Trans Co
- Sales and profits rose, but net income fell 6% year-over-year; outlook remains cautious.9357
Q1 202513 Mar 2026 - Profits and dividends rose, but FY2026 forecasts slight declines in sales and profit.9357
Q4 202513 Mar 2026 - Profits rose on higher sales, but comprehensive income fell due to securities valuation losses.9357
Q3 202513 Mar 2026 - Strong quarterly profit growth, but full-year outlook signals lower earnings ahead.9357
Q1 202613 Mar 2026 - Profits and comprehensive income rose, but full-year guidance forecasts a slight decline.9357
Q2 202613 Mar 2026 - Profits and comprehensive income rose sharply, but full-year guidance signals a modest decline.9357
Q3 202613 Mar 2026